EVP & Chief Medical Officer of Incyte Corp (30-Year Financial, Insider Trades) Steven H Stein (insider trades) sold 14,769 shares of INCY on 07/08/2020 at an average price of $109.52 a share. The total sale was $1.6 million.
Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis. Incyte Corp has a market cap of $23.62 billion; its shares were traded at around $108.64 with and P/S ratio of 10.60. GuruFocus has detected 2 severe warning signs with Incyte Corp. .
Directors and Officers Recent Trades:
- EVP GPS, BD, & Licensing Vijay K Iyengar sold 3,595 shares of INCY stock on 07/08/2020 at the average price of $108.06. The price of the stock has increased by 0.54% since.
- EVP & Chief Medical Officer Steven H Stein sold 14,769 shares of INCY stock on 07/08/2020 at the average price of $109.52. The price of the stock has decreased by 0.8% since.
- President Herve Hoppenot sold 89,771 shares of INCY stock on 07/07/2020 at the average price of $110. The price of the stock has decreased by 1.24% since.
- EVP, Head of Discovery Chem Yao Wenqing sold 16,553 shares of INCY stock on 07/06/2020 at the average price of $107.32. The price of the stock has increased by 1.23% since.
- EVP & Chief Medical Officer Steven H Stein sold 36,124 shares of INCY stock on 07/06/2020 at the average price of $107.25. The price of the stock has increased by 1.3% since.
For the complete insider trading history of INCY, click here
.
